Please login to the form below

Not currently logged in
Email:
Password:

dosing

This page shows the latest dosing news and features for those working in and with pharma, biotech and healthcare.

Bayer roll-out of haemophilia drug Jivi gathers pace

Bayer roll-out of haemophilia drug Jivi gathers pace

Jivi is another option in an increasingly crowded market for haemophilia A therapies, and Bayer is hoping that the new products dosing schedule will prove popular with patients and physicians.

Latest news

  • Teva wins FDA OK for crucial migraine drug Teva wins FDA OK for crucial migraine drug

    The FDA approved the CGRP inhibitor for the prevention of migraine in adults with either monthly or quarterly dosing, based on two phase 3 studies showing that it could reduce the ... With Lilly due to hear from the FDA any day now, potentially setting

  • BMS psoriasis drug hits the mark in phase II BMS psoriasis drug hits the mark in phase II

    If approved, BMS-986165’s oral dosing could give it a leg-up over these injectable drugs but it will still need to take on Otezla and generic oral agents like

  • Pfizer abandons antibody for Duchenne Pfizer abandons antibody for Duchenne

    Pfizer started dosing patients with its mini-dystrophin candidate in March, and early data from the trial is due next year.

  • Shire claims US okay for HAE blockbuster-in-waiting Shire claims US okay for HAE blockbuster-in-waiting

    The phase III HELP study showed that two-weekly dosing of the antibody by the patients themselves resulted in an 87% reduction in the mean frequency of HAE attacks compared to

  • ViiV chalks up another win for two-drug HIV regimen ViiV chalks up another win for two-drug HIV regimen

    GlaxoSmithKline unit ViiV has shown that a two-drug HIV regimen given just once a month by injection can match the efficacy of daily, oral dosing with triple therapy. ... If approved, this regimen would give people living with HIV one month between each

More from news
Approximately 2 fully matching, plus 425 partially matching documents found.

Latest Intelligence

  • How can pharma build bridges with HCPs online? How can pharma build bridges with HCPs online?

    The programme enabled users to click through to a landing page with content specific to the product’s indications and dosing regimens, plus external links to NICE guidance, clinical data and

  • How Augmented reality is disrupting healthcare How Augmented reality is disrupting healthcare

    Differentiation with AR could highlight better efficacy, address new uses or dosing, or build awareness by leveraging an emotional aspect of the product.

  • Communication is the key to the participatory medicine model Communication is the key to the participatory medicine model

    If patients are more engaged in their treatment decisions, then they can consider what matters to them in approaching treatment - whether that be administration method, dosing frequency or the likelihood of

  • The good, the bad and the ugly The good, the bad and the ugly

    Small factors like position to market, route of administration and dosing frequency will play a large role in deciding market share.”.

  • Gene therapy Gene therapy

    However, the pathogenic origins of viral vectors and associated immune response mounted against them is their biggest limiting factor as it precludes regular or even repeat dosing.

More from intelligence
Approximately 0 fully matching, plus 17 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 6 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wilmington Healthcare

A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics